Matinas Biopharma Holdings, Inc. revenue breakdown overview

Matinas Biopharma Holdings, Inc. revenue for the last year amounted to 1.10 M USD, the most of which — 1.10 M USD — came from its highest performing source at the moment, Novel Pharmaceutical Products, the year earlier bringing 3.19 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Matinas Biopharma Holdings, Inc. 1.10 M USD, and the year before that — 3.19 M USD.